➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: July 12, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for ISV-305

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug ISV-305?

ISV-305 is an investigational drug.

There have been 15 clinical trials for ISV-305. The most recent clinical trial was a Phase 3 trial, which was initiated on December 4th 2019.

The most common disease conditions in clinical trials are Cataract, Inflammation, and Conjunctivitis, Bacterial. The leading clinical trial sponsors are InSite Vision, Bausch & Lomb Incorporated, and University of California, San Diego.

There are two US patents protecting this investigational drug and forty-three international patents.

Recent Clinical Trials for ISV-305
Rib Fracture Analgesia Using CryoanalgesiaEpimed InternationalPhase 4
Rib Fracture Analgesia Using CryoanalgesiaUniversity of FloridaPhase 4
Rib Fracture Analgesia Using CryoanalgesiaUniversity of California, San DiegoPhase 4

See all ISV-305 clinical trials

Clinical Trial Summary for ISV-305

Top disease conditions for ISV-305
Top clinical trial sponsors for ISV-305

See all ISV-305 clinical trials

US Patents for ISV-305

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
ISV-305   Start Trial IBAT inhibitors for the treatment of liver diseases Albireo AB (Gothenburg, SE)   Start Trial
ISV-305   Start Trial Therapeutic/ preventive agent containing coumarin derivative as active ingredient NIPPON ZOKI PHARMACEUTICAL CO., LTD. (Osaka-shi, JP)   Start Trial
ISV-305   Start Trial Low, immune enhancing, dose mtor inhibitors and uses thereof Novartis AG (Basel, CH)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.